Free Trial

BioNexus Gene Lab (BGLC) Earnings Date, Estimates & Call Transcripts

BioNexus Gene Lab logo
$0.38
+0.02 (+5.60%)
(As of 11/1/2024 ET)

BioNexus Gene Lab Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 18Estimated
Actual EPS
(Aug. 14)
$0.01 Beat By $0.01

BioNexus Gene Lab issued Q2 2024 earnings on August 14, 2024, reporting an EPS of $0.01. Quarterly revenue was reported to be $1.98 million. BioNexus Gene Lab currently has a trailing EPS of $0.00

BGLC Upcoming Earnings

BioNexus Gene Lab's next earnings date is estimated for Monday, November 18, 2024, based off prior year's reporting schedules.

Get BioNexus Gene Lab Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNexus Gene Lab and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BGLC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BGLC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioNexus Gene Lab Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/18/2024
(Estimated)
------- 
8/14/2024Q2 2024-$0.01+$0.01$0.01-$1.98M
5/15/2024Q1 2024--$0.02 -$0.02-$0.02-$2.38M
11/20/2023Q3 2023--$0.02 -$0.02-$0.02-$2.55M


This page (NASDAQ:BGLC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners